A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa
Public ClinicalTrials.gov record NCT07007637. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Open-label Extension Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a study to evaluate the long-term safety, tolerability, and efficacy of sonelokimab in participants with moderate to severe hidradenitis suppurativa who were previously enrolled in a parental study.
Study identification
- NCT ID
- NCT07007637
- Recruitment status
- Enrolling by invitation
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 835 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 27, 2025 (Actual)
- Primary completion
- Jun 13, 2028 (Estimated)
- Completion
- Jun 13, 2028 (Estimated)
- Last update posted
- Jun 8, 2026
2025 – 2028
United States locations
- U.S. sites
- 49
- U.S. states
- 23
- U.S. cities
- 43
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Site | Birmingham | Alabama | 35244 | — |
| Clinical Site | North Little Rock | Arkansas | 72117 | — |
| Clinical Site | Los Angeles | California | 90404 | — |
| Clinical Site | Northridge | California | 91325 | — |
| Clinical Site | Aventura | Florida | 33180 | — |
| Clinical Site | Coral Gables | Florida | 33134 | — |
| Clinical Site | Hialeah | Florida | 33012 | — |
| Clinical Site | Hollywood | Florida | 33021-6746 | — |
| Clinical Site | Miami | Florida | 33136 | — |
| Clinical Site | Miami | Florida | 33163 | — |
| Clinical Site | Ocala | Florida | 34471 | — |
| Clinical Site | Tampa | Florida | 33607 | — |
| Clinical Site | Tampa | Florida | 33613 | — |
| Clinical Site | Macon | Georgia | 31217 | — |
| Clinical Site | Sandy Springs | Georgia | 30328 | — |
| Clinical Site | Skokie | Illinois | 60077 | — |
| Clinical Site | West Dundee | Illinois | 60118 | — |
| Clinical Site | Columbus | Indiana | 47201 | — |
| Clinical Site | New Albany | Indiana | 47150 | — |
| Clinical Site | Plainfield | Indiana | 46168 | — |
| Clinical Site | Louisville | Kentucky | 40241 | — |
| Clinical Site | Murray | Kentucky | 42071 | — |
| Clinical Site | Metairie | Louisiana | 70006 | — |
| Clinical Site | Boston | Massachusetts | 02116 | — |
| Clinical Site | Boston | Massachusetts | 02215 | — |
| Clinical Site | Ann Arbor | Michigan | 48109-5314 | — |
| Clinical Site | Canton | Michigan | 48187 | — |
| Clinical Site | Clarkston | Michigan | 48346 | — |
| Clinical Site | Waterford | Michigan | 48328 | — |
| Clinical Site | New Brighton | Minnesota | 55112 | — |
| Clinical Site | Omaha | Nebraska | 68144 | — |
| Clinical Site | Las Vegas | Nevada | 89148 | — |
| Clinical Site | New York | New York | 10003 | — |
| Clinical Site | New York | New York | 10012 | — |
| Clinical Site | The Bronx | New York | 10467 | — |
| Clinical Site | Fargo | North Dakota | 58103 | — |
| Clinical Site | Boardman | Ohio | 44512 | — |
| Clinical Site | Columbus | Ohio | 43213 | — |
| Clinical Site | Dayton | Ohio | 45324 | — |
| Clinical Site | Oklahoma City | Oklahoma | 73118 | — |
| Clinical Site | Murfreesboro | Tennessee | 37130 | — |
| Clinical Site | Dallas | Texas | 75235 | — |
| Clinical Site | Dallas | Texas | 75246 | — |
| Clinical Site | Houston | Texas | 77004 | — |
| Clinical Site | San Antonio | Texas | 78213 | — |
| Clinical Site | San Antonio | Texas | 78218 | — |
| Clinical Site | South Jordan | Utah | 84095 | — |
| Clinical Site | Mill Creek | Washington | 98012 | — |
| Clinical Site | Morgantown | West Virginia | 26505 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 117 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07007637, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 8, 2026 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07007637 live on ClinicalTrials.gov.